382 related articles for article (PubMed ID: 30376860)
1. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
[TBL] [Abstract][Full Text] [Related]
2. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
[TBL] [Abstract][Full Text] [Related]
3. Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial.
Byakika-Kibwika P; Achan J; Lamorde M; Karera-Gonahasa C; Kiragga AN; Mayanja-Kizza H; Kiwanuka N; Nsobya S; Talisuna AO; Merry C
BMC Infect Dis; 2017 Dec; 17(1):794. PubMed ID: 29281988
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum clearance time in Malawian children with cerebral malaria: a retrospective cohort study.
Saidi AM; Guenther G; Izem R; Chen X; Seydel K; Postels D
Malar J; 2021 Oct; 20(1):408. PubMed ID: 34663346
[TBL] [Abstract][Full Text] [Related]
5. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
[TBL] [Abstract][Full Text] [Related]
6. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
8. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
Maiga AW; Fofana B; Sagara I; Dembele D; Dara A; Traore OB; Toure S; Sanogo K; Dama S; Sidibe B; Kone A; Thera MA; Plowe CV; Doumbo OK; Djimde AA
Am J Trop Med Hyg; 2012 Jul; 87(1):23-8. PubMed ID: 22764287
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
[TBL] [Abstract][Full Text] [Related]
10. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
[TBL] [Abstract][Full Text] [Related]
11. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
Maka DE; Chiabi A; Ndikum V; Achu D; Mah E; Nguefack S; Nana P; Njoumemi Z; Mbacham W; Mbonda E
Malar J; 2015 Oct; 14():429. PubMed ID: 26520401
[TBL] [Abstract][Full Text] [Related]
13. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
[TBL] [Abstract][Full Text] [Related]
16. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
17. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
[TBL] [Abstract][Full Text] [Related]
18. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
Sowunmi A; Akano K; Ayede AI; Adewoye EO; Ntadom G; Fatunmbi B; Gbotosho GO; Folarin OA; Happi CT
BMC Infect Dis; 2017 Jan; 17(1):110. PubMed ID: 28143417
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
[TBL] [Abstract][Full Text] [Related]
20. Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.
Kone A; Sissoko S; Fofana B; Sangare CO; Dembele D; Haidara AS; Diallo N; Coulibaly A; Traore A; Toure S; Haidara K; Sanogo K; Sagara I; Beshir KB; Gil JP; Doumbo OK; Djimde AA
Int J Infect Dis; 2020 Jun; 95():399-405. PubMed ID: 32320811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
